SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06001827

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
VenoStent (from the registry)
Registry
  • NCT NCT06001827
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06001827. Randomized; double masking; primary purpose treatment. Start 2024-01-03 (actual); primary completion 2027-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Acronym
SAVE-FistulaS
Condition
Chronic Kidney Diseases
Condition
End Stage Renal Disease
Condition
Arteriovenous Fistula
Condition
Hemodialysis Access Failure
Condition
ESRD
Condition
Vascular Access Complication
Condition
Renal Failure
Condition
Catheter Complications
Condition
Catheter Dysfunction
Condition
Renal Insufficiency
Intervention (Device)
SelfWrap Bioabsorbable Perivascular Wrap
Intervention (Procedure)
Untreated AVF Control
Lead sponsor
VenoStent (class: industry)

Record details

Record id
cardio:ct-nct06001827
Content hash
8bb705a2cf9ad0720a500cf67900037d1be17b970bd8be369bace9ff9c29f31a